arrow
L

Li Zhang

State Key Lab Oncology South China
H指数:33
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical features and outcomes of unresectable locally advanced lung adenocarcinoma with uncommon EGFR mutations: a retrospective multi-center Chinese study

具有罕见EGFR突变的无法切除的局部晚期肺腺癌的临床特征和预后: 一项回顾性多中心中国研究

2025-01-010
OAAI
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAFV600E mutation-positive metastatic non-small cell lung cancer

达拉非尼联合曲美替尼治疗中国BRAFV600E突变阳性转移性非小细胞肺癌患者的疗效、安全性和生活质量

2024-12-010
OAAI
EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study

Egfr-tkis联合立体定向放疗 (SBRT) 治疗IV期非小细胞肺癌 (NSCLC): 一项前瞻性,多中心,随机,对照的II期研究

2023-07-0120
OAAI
Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

成人3剂SARS-CoV-2灭活疫苗的免疫原性和安全性: 一项随机,双盲,安慰剂对照的2期试验

2021-12-2711
OA